Title of article
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
Author/Authors
Response monitoring of neoadjuvant therapy using CT، نويسنده , , DANN^EUS، A. نويسنده , , and FDG-PET، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
17
From page
941
To page
957
Abstract
Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an effort to improve prognosis. However, in a substantial fraction of patients there is no response to this non-surgical therapy. Non-invasive imaging modalities such as computed tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) have been evaluated for assessing patient response to therapy, and these are described in this review. Currently, FDG-PET seems to be the best available tool for neoadjuvant therapy response assessment in oesophageal cancer.
Keywords
CT , neoadjuvant therapy , Oesophageal cancer , EUS , therapy response assessment , FDG-PET.
Journal title
Best Practice and Research Clinical Gastroenterology
Serial Year
2006
Journal title
Best Practice and Research Clinical Gastroenterology
Record number
466614
Link To Document